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CHAPTER 1 
 
ISOFORMS OF p120 
 
Introduction 
     p120-catenin (hereafter referred to as p120) is an Armadillo repeat domain protein that 
regulates cadherin-catenin complex stability at cell-cell junctions.  In addition to its 
structural role, p120 is a signaling molecule that mediates actin cytoskeletal dynamics 
through interactions with small Rho GTPases and it intercedes with the canonical Wnt 
pathway through binding to the transcriptional repressor Kaiso.  It is the prototypic 
member of a protein family that includes Armadillo Repeat deleted in Velo-Cardio Facial 
syndrom (ARVCF), δ-catenin, p0071, and plakophilins 1-3 (Reynolds, 2007; Carnahan et 
al., 2010).  The p120 gene (CTNND1) encodes multiple isoforms with cell type-specific 
expression and dramatically different capabilities.  The aforementioned roles have been 
the subject of recent reviews (Hartsock and Nelson, 2008; Pieters et al., 2012; Menke and 
Giehl, 2012).  This introduction will address these topics with a focus on the specific 
involvement of different p120 isoforms and family members.  The final portion of the 
chapter will discuss emerging functions of p120 in neural development and function. 
     CTNND1 hypothetically encodes 48 alternatively spliced isoforms that range in size 
from about 75 – 120 kDa.  These isoforms comprise combinations of 4 different ATG 
start sites (1-4) and 4 alternatively spliced exons (A-D) (Keirsebilck et al., 1998; Mo and 
Reynolds, 1996; Aho et al., 1999) (Fig. 1).  The longest isoforms contain an N-terminal 
head domain with a coiled-coil motif and a regulatory region that contains most, but not  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Schematic of p120 catenin isoforms and conserved domains.  Full-length p120 
is shown at the top with the conserved head domain, alternative translational start codons 
1-4, and alternatively spliced exons A-D.  Tyrosine phosphorylation sites are indicated 
with green markers and serine/threonine sites with red markers.  Shorter isoforms starting 
at site 3 are associated with epithelial cells (shown on left as hexagons).  EMT or 
tumorigenesis can induce a switch to increased relative amounts of longer p120-1 
isoforms in mesenchymal cells (triangles).  DIPA binds to the N-terminal coiled-coil of 
p120-1.
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all, of the p120 tyrosine and serine/threonine phosphorylation sites.  The central 
Armadillo repeat domain is required for binding to cadherins, regulating small Rho 
GTPases, and mediating Kaiso transcriptional repression (Ishiyama et al., 2010; 
Anastasiadis et al., 2000; Daniel and Reynolds, 1999).  The C-terminal tail of p120 has a 
poorly understood function confounded by the largely unknown functions of alternatively 
spliced exons A and B. 
     p120 is expressed almost ubiquitously.  However, it is predominately located at the 
baso-lateral plasma membrane of epithelial cells and also enriched at synaptic densities in 
neurons and intercalated discs in cardiomyoctyes.  Less abundant p120 protein is 
diffusely cytoplasmic in some epithelial and other cell types, including fibroblasts and 
adipocytes (Golenhofen and Drenckhahn, 2000).  Mo and Reynolds were the first to 
show that the two major p120 isoforms are generated by alternative translation initiation 
codons 1 or 3.  They showed that fibroblasts and macrophages preferentially express the 
longer p120 isoform 1, whereas epithelial cells tend to have higher expression of the 
shorter p120 isoform 3.  They also observed that MDCK epithelial cells up-regulate 
expression of long isoforms when transformed with v-src (Mo and Reynolds, 1996).  
Isoforms beginning with start codon 2 are rarely detected, and those beginning with 
codon 4 are only detected in low abundance (Keirsebilck et al., 1998).  Exon C is 
expressed at low levels except in brain tissues, the same location where isoforms lacking 
exon D are observed (Keirsebilck et al., 1998; Aho et al., 1999). 
     The two major isoforms have different affects on cellular motility.  One hypothesis 
predicts that p120 isoform 1 (long) is predominant in mesenchymal cells because it 
influences adherens junctions to permit or promote migration, while p120 isoform 3 
4 
(short) is predominant in epithelial cells to regulate adhesion of non-migrating cells.  
Importantly, both of these major isoforms are equally capable of binding to E-cadherin 
(Reynolds et al., 1996), so their differences are not based simply on affinity.  In the 
mouse, p120 isoform 3 is enriched at cell junctions of glandular, mucosal, and epidermal 
cells, which require adherens junction stability to maintain tissue integrity and apico-
basolateral polarity.  In the same study, p120 isoform 1 staining is abundant in the 
endothelium, myocardium, serosal epithelia, and choroid plexus (Montonen et al., 2001).  
Unlike macrophages, these cells do not rely on motility for their function, but they may 
require p120 isoform 1 for highly specialized functions. 
     The most well studied function of p120 is its regulation of classical cadherins.  
Cadherins are single transmembrane proteins that homodimerize via extracellular 
domains to create calcium-dependent intercellular contacts (Fig. 2).  Type I and II 
cadherins are the core structure of adherens junctions, which initiate and maintain cell-
cell adhesion while establishing apico-basolateral polarity (Harris and Tepass, 2010; 
Hartsock and Nelson, 2008; McNeill et al., 1993).  Vertebrates have 26 cadherins that are 
defined by their five extracellular cadherin (EC) domains and conserved cytoplasmic tail 
(Gallin, 1998; Hulpiau and Roy, 2009).  p120 belongs to a family of intracellular proteins 
called catenins (from the Latin catena, meaning “chain”) that link cadherins to the actin 
cytoskeleton for establishing and strengthening cell-cell contacts 
 (Harris and Tepass, 2010; Hatsell et al., 2003; Ozawa et al., 1989).  Catenins are also 
critical for morphogenic and mitogenic signaling pathways, of which β-catenin is the 
most well characterized.  It is the key signaling molecule in the canonical Wnt pathway, 
which is important for normal development and cancer, reviewed in (Polakis, 2012).   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  p120 is a master regulator of cadherin stability and adherens junctions.  p120-1 
typically associates with N-cadherin and p120-3 with E-cadherin.  DIPA co-localizes 
with p120-1 and N-cadherin.  β-catenin and α-catenin interact with cadherins and 
stabilize the actin cytoskeleton.  p120 can regulate RhoA through p190RhoGAP at 
adherens junctions or directly in the cytoskeleton.  p120 sequesters Kaiso in the 
cytoplasm from its dual role as a transcriptional repressor with SMRT and a Wnt pathway 
inhibitor by blocking TCF/β-catenin binding.
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p120, α-catenin, β-catenin, and plakoglobin all associate with the cytoplasmic domain of 
classical cadherins (Fig 1).  Specifically, p120 binds to the juxtamembrane domain 
(JMD) of the cadherin cytoplasmic tail via its conserved Arm-repeat domain (Ishiyama et 
al., 2010; Ohkubo and Ozawa, 1999; Reynolds et al., 1994; Shibamoto et al., 1995; Yap 
et al., 1998).  β-catenin and plakoglobin can compete for binding to the more C-terminal 
catenin-binding domain (CBD) of cadherins (Adams et al., 1996).  Monomeric α-catenin 
binds directly to β-catenin and functionally links the cadherin complex to the actin 
cytoskeleton (Drees et al., 2005; Yamada et al., 2005). 
     Different p120 isoforms have variable, and sometimes opposing, effects on cadherin 
stabilization.  Over-expression studies have produced results suggesting that the 
phosphorylated N-terminal regulatory domain, which is missing in p120 isoform 4, 
inhibits junctional stability (Aono et al., 1999; Ireton et al., 2002; Ozawa and Ohkubo, 
2001).  More recent reports contend that phosphorylation status of the regulatory domain 
is responsible for this effect.  For example, serine and threonine phosphorylation 
enhances efficient junction recovery during calcium switch assays (Fukumoto et al., 
2008).  Although p120 was initially described as an efficient Src substrate, the 
mechanisms of adherens junction phospho-regulation remain unclear.  Unlike other Src 
substrates, p120 tyrosine phosphorylation occurred only with transformation-inducing 
Src mutations (Reynolds et al., 1989), suggesting that p120 phosphorylation is an integral 
part of v-src-induced transformation.  With respect to isoforms, the major phosphorylated 
sites are present in all p120 isoforms except those beginning at start site 4, which are not 
commonly expressed in vivo.  A detailed discussion of p120 phosphorylation is beyond 
the scope of this review, but the relationships between p120 isoforms and cadherins will 
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be addressed in a subsequent section. 
The p120 subfamily 
     p120 is the prototypic member of a subfamily of catenin proteins that also interact 
with the JMD of classical cadherins.  p120 and the six other subfamily members in 
vertebrates: ARVCF, δ-catenin, p0071, and plakophilins 1-3 are evolutionarily derived 
from a single δ-catenin-like ancestor (Carnahan et al., 2010).  ARVCF (Armadillo Repeat 
gene deleted in Velo-Cardio-Facial Syndrome), δ-catenin, and p0071 all contain a central 
armadillo repeat domain, an N-terminal regulatory region with a coiled-coil domain, and 
a C-terminal region with a PDZ ligand domain.  Notably, p120 lacks the C-terminal PDZ, 
which may be a key structural trait that has allowed p120 to become the dominant 
subfamily member in vertebrates (Carnahan et al., 2010).  Another feature is the ability of 
p120 to undergo alternative splicing, a trait shared in the mammalian subfamily only by 
ARVCF (Waibler et al., 2001).  Xenopus δ-catenin reportedly has three alternative 
translation initiation codons and three alternatively spliced exons (Gu et al., 2009).  
ARVCF localizes to adherens junctions and binds to the JMD of classical cadherins via 
its armadillo repeat domain in a manner mutually exclusive to p120 (Kaufmann et al., 
2000; Paulson et al., 2000).  It can also bind to ZO-1 and ZO-2 proteins at tight junctions 
through its PDZ ligand domain, which has also been implicated in ARCFV nuclear 
translocation (Kausalya et al., 2004; Mariner et al., 2000).  Like ARVCF, δ-catenin and 
p0071 can compete with p120 for E-cadherin binding (Hatzfeld et al., 2003; Lu et al., 
1999; Yang et al., 2010).  The mechanism of ARVCF activity in development and 
neuronal function is unclear, but it is genetically associated with Velo-Cardio-Facial 
Syndrome, DiGeorge Syndrome, and schizophrenia (Mas et al., 2010; Sirotkin et al., 
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1997).  Similarly, δ-catenin deletion is associated with mental retardation and adult facial 
dysmorphism in Cri-du-chat syndrome (Church et al., 1995; Medina et al., 2000). The 
complicated relationship between p120 subfamily members and neuro-developmental 
disorders will be examined in more detail at the end of this chapter.  
     The plakophilins 1-3 are more distantly related to p120, and while they do have a 
conserved armadillo repeat domain, they do not interact with classical cadherins.  They 
do, however, bind to desmosomal cadherins via their N-terminal head domain (Chen et 
al., 2002; Hatzfeld et al., 2000; Kowalczyk et al., 1999). 
     p120 and its subfamily members have overlapping expression patterns throughout 
mammalian tissue, but they do not always have redundant functions.  For example, δ-
catenin, ARVCF, and p0071 are all expressed in mammary tissue.  But in mice with p120 
genetically deleted, these family members do not restore cadherin stability (Kurley et al., 
2012).  Despite the structural similarities among the p120 subfamily members, they are 
not always capable of functional redundancy. 
 
Epithelial-to-Mesenchymal Transition 
     Epithelial-to-mesenchymal transition (EMT) is a set of cellular programs that confer 
on epithelial cells the ability to disassemble cell-cell adhesions, obtain mesenchymal 
characteristics, re-establish plasticity, and migrate through the extra-cellular matrix 
(Acloque et al., 2009).  These changes within the cell are mediated by EMT transcription 
factors, like Snail, Slug, Twist, and Zeb (Thiery et al., 2009).  The molecular mechanisms 
of EMT generally include reprogramming of epigenetic regulation, suppression of E-
cadherin and tight junction proteins, and up-regulation of certain mesenchymal proteins, 
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such as N-cadherin, Vimentin, and Smooth Muscle Actin (Peinado et al., 2004).  
Physiologic EMT programs are essential for embryogenesis.  In this case, the expression 
of EMT transcription factors is regulated by secreated factors such as TGFβ, Wnt, and 
Notch ligands (Thiery et al., 2009).  EMT is also required for maintaining homeostasis 
during wound healing, in which TGFβ signaling is particularly important (Weber et al., 
2012).  In metastasis, cancer cells hijack EMT mechansims in order to invade local 
tissue, resist apoptosis, and colonize distant sites.  The main goal of migrating to a distant 
site and establishing new cells is common among these processes.  The major 
transcription factors that regulate physiologic and pathologic EMT are the same, too.  
Also, the microenvironment-dependent initiation of EMT by growth factors and 
morphogenes is similar.  Key differences such as the capability to self-renew, suppress 
apoptosis, and induce immunosuppression separate metastatic EMT from normal 
physiologic processes (Scheel and Weinberg, 2012). 
     Its function in EMT programs may be unclear, but p120-1 is clearly associated with 
metastasis in human cancer.  The association between abnormal p120 expression and 
cancer has been known for a decade (Thoreson and Reynolds, 2002).  Recently, studies 
have distinguished the prevalence of specific p120 isoforms in metastatic disease.  In 
breast, lung, and renal cell cancers, p120-1 expression is positively correlated with 
metastasis and is an independent predictor of poor prognosis  (Miao et al., 2010; Talvinen 
et al., 2010; Yanagisawa et al., 2008).  In contrast, a study of lung squamous cell cancer 
and adencocarcinoma reports that p120-1 negatively correlates with lymph node 
metastasis, whereas p120-3 exhibits a positive correlation (Liu et al., 2007). 
     The phenomenon of p120 isoform switching in metastatic disease is supported by 
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mechanistic studies in tissue culture.  The p120-3 to p120-1 switch is observed in 
epithelial cells with the exogenous expression of EMT transcription factors SIP1/ZEB2, 
Snail, E47, or Slug (Ohkubo and Ozawa, 2004; Sarrió et al., 2004; Vandewalle et al., 
2005).  In addition, the novel metastasis promoter, Zeppo1, confers an invasive 
phenotype on mammary epithelial cells and induces a p120 isoform switch (Slorach et 
al., 2011).  Potentially, p120-1 and p120-3 differentially regulate the Rho family of small 
GTPases, which function in EMT-associated cytoskeletal remodeling, cellular protrusion 
formation, and motility (Aono et al., 1999; Ohkubo and Ozawa, 1999; Ozawa and 
Kemler, 1998). 
 
Regulation of Rho GTPase Activity 
     Rho, Rac, and Cdc42 are the principal members of a GTPase subfamily that controls 
cytoskeletal formation, motility, polarity, and proliferation.  p120 inhibits RhoA via 
interaction with the RhoGEF Vav2 and p190RhoGAP (Noren et al., 2000; Wildenberg et 
al., 2006).  In fact, p120 recruitment of p190RhoGAP to the cell membrane is required 
for Rac-dependent inhibition of Rho in fibroblasts (Wildenberg et al., 2006).  p120 can 
also directly bind to Rho and act as a GDI (guanine-nucleotide dissociation inhibitor) 
(Anastasiadis et al., 2000) (Fig. 2).  In vivo, p120 inhibition of RhoA in the skin is 
required to depress NFκB-mediated inflammation (Perez-Moreno et al., 2006).  p120 
isoform 1A has an increased ability to bind inactivated RhoA compared to shorter 
isoforms, which may explain its ability to promote invasion in breast and lung cancer 
cells (Liu et al., 2009; Yanagisawa et al., 2008).  However, exogenous p120-1 and p120-
3, but not the shorter p120-4, can inhibit RhoA as is evident by their induction of a 
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“dendritic branching” cellular morphology (Aho et al., 2002). 
     The widely accepted effect of p120 on Rac1 and Cdc42 is to induce their activation 
(Grosheva et al., 2001; Johnson et al., 2010) (Fig. 2).  However, studies in pancreatic 
cancer cells lacking PPARγ suggest that p120 has the opposite effect (Nakajima et al., 
2008).  With regard to specific isoforms, Liu et al. show that p120-1A over-expressed in 
A549 cells can deactivate Rac1.  Similarly, exogenous p120-3A down-regulates Cdc42 
but up-regulates RhoA (Liu et al., 2009).  The context of each system clearly contributes 
to the observed effect of p120.  It must also be appreciated that Rac1 and Cdc42 facilitate 
the trafficking of E-cadherin and the formation of adherens junctions (Wang et al., 2005), 
so opposing data may reflect GTPase activity at different points within a feedback loop. 
     p120 interaction with Rho GTPases is also important for tumorigenesis.  In Rac- and 
Src-transformed MDCK cells, p120 inhibition of RhoA is required for growth in soft agar 
media (Dohn and Reynolds, 2009).  Unpublished data from our lab show that exogenous 
p120-1A, but not p120-3A, can rescue this anchorage-independent growth in the absence 
of endogenous p120.  Since both isoforms can equally stabilize E-cadherin, their 
differential interaction with RhoA, or some other binding partner, is likely responsible for 
the isoform-specific rescue.  Independently of Rho activity, p120 is required for Rac1 
activation and transformed cell growth in E-cadherin-deficient cells (Soto et al., 2008).  
There is no significantly different impact on Rac1 activity between p120 isoforms 
(Yanagisawa et al., 2008), but this area has not been extensively studied. 
     p120 subfamily members also regulate Rho GTPases in a context-dependent manner 
that is essential for normal development.  For example, δ-catenin can induce dendrite-like 
branching in NIH3T3 cells similarly to p120.  This effect is reproducible in primary 
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hippocampal neurons where neurite branching and δ-catenin are abundant in vivo.  
Unlike p120, the branching phenotype is inhibited by δ-catenin C-terminal truncation 
mutants (Kim et al., 2002), suggesting that the C-terminal PDZ domain interacts with an 
essential co-factor for RhoA inhibition.  Other binding partners may mediate a balance 
between neurite branching and elongation by inhibiting RhoA through a complex that 
involves phosphorylation-dependent binding of δ-catenin to cortactin, an actin 
cytoskeleton linker protein (Martinez et al., 2003).  Morpholino knockdown experiments 
in Xenopus show that ARVCF and p120 are required to inhibit RhoA and activate Rac for 
normal early development (Fang et al., 2004).  The same results were observed with δ-
catenin knockdown in Xenopus  (Gu et al., 2009).  ARVCF inhibition of RhoA activity 
may depend on its interaction with the cytoskeletal regulators KazrinA and 
p190RhoGAP. δ-catenin and p0071, but not p120, can bind to KazrinA as well (Cho et 
al., 2010).  p0071 regulates RhoA specifically during cytokinesis.  It binds to Ect2, a Rho 
GEF, to activate RhoA at the cleavage furrow.  Over-expression or knockdown of p0071 
causes a failure of cytokinesis leading to multinucleated cells and apoptosis (Keil et al., 
2007; Wolf et al., 2006).  The p120 subfamily members appear to have some redundant 
function, but there are distinct differences that have evolved to regulate GTPase 
activation either directly or indirectly.  It appears that these functional differences are 
emerging not as the exception but as the rule. 
 
p120, Kaiso, and Wnt signaling 
     Kaiso was initially described as a novel p120 binding partner through yeast two-
hybrid screening (Daniel et al., 1999).  Kaiso is a transcriptional regulator containing an 
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N-terminal BTB/POZ domain (Broad complex, Tramtrak, Bric à brac/Pox Virus and Zinc 
finger) and a C-terminal zinc finger domain.  It belongs to a family of BTB/POZ-zinc 
finger proteins that includes ZBTB4, BCL-6, PLZF, and others implicated in cancer and 
development (Carnahan et al., 2010; Daniel, 2007).  The BTB/POZ domain is a protein-
protein interaction motif that is required for Kaiso homodimerization and binding to 
CTCF and NCoR, a vertebrate insulator protein and histone deacetylase, respectively 
(Defossez et al., 2005; Yoon et al., 2003).  The zinc finger region contains three C2H2 
fingers and is necessary for binding directly to p120 and DNA  (Daniel and Reynolds, 
1999).  Kaiso and p120 interact in an isoform-dependent manner in which only p120-3 
can directly bind to Kaiso  (Dai et al., 2009; Jiang et al., 2012; Zhang et al., 2011).  
     Kaiso mediates transcriptional repression of Wnt target genes through binding to 
either a specific consensus sequence or methylated CpG pairs (Buck-Koehntop et al., 
2012; Daniel et al., 2002).  Wnt-11, siamois, matrilysin, MTA2, and cyclinD1 are among 
the putative Kaiso target genes (Kim et al., 2004; Park et al., 2005; Spring et al., 2005; 
Yoon et al., 2003).  More recent data suggest that Kaiso does not require DNA binding 
for its transcriptionally repressive function.  Instead, Kaiso binds directly to TCF family 
members and blocks their interaction with DNA, thus inhibiting the canonical Wnt 
pathway (Ruzov et al., 2009; Ruzov et al., 2009) (Fig. 2).  High-throughput ChIP-seq 
data suggest that Kaiso is not specifically a Wnt-related protein (Raghav et al., 2012).  
Prior to terminal differentiation into adipocytes, mesenchymal cells express Kaiso, which 
guides the transcriptional co-repressor SMRT to DNA promoter elements of key 
adipogenic genes (Raghav et al., 2012) (Fig. 2). 
     The interaction between p120 and Kaiso has been extensively studied in examination 
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of the canonical Wnt pathway.  In a subcloned SW480 colorectal cancer cell line, p120 
constitutively binds to CK1ε, and upon Wnt3a treatment, p120 Ser268 is phosphorylated 
by CK1ε, which activates p120-3 to form an exclusively cytoplasmic complex with Kaiso  
(Casagolda et al., 2010; Valle-Perez et al., 2011) (Fig. 2).  These data support earlier 
findings that reveal a positive-feedback loop in which Wnt-induced stabilization of p120 
sequesters Kaiso to relieve inhibition of Wnt signaling  (Park et al., 2005).  In support of 
this model, p120-1A over-expression during Xenopus development results in similar 
defects as Kaiso null mutants (Paulson et al., 1999).  Kaiso ablation results in multiple 
developmental defects, consistent with its inhibition of Wnt signaling (Kim et al., 2004).  
In Xenopus embryos and HEK293T cells, the dual-specificity kinase Dyrk1A positively 
stabilizes p120-1 in the nucleus, which leads to Kaiso sequestration and de-repression of 
the Wnt target genes Siamois and Wnt11 (Hong et al., 2012).  p120-mediated de-
repression of Kaiso target genes has also been shown in breast, gastric, and endothelial 
cells (Ogden et al., 2008; Vermeulen et al., 2012; Zhang et al., 2010).  Considering earlier 
work that showed only p120-3 can bind Kaiso directly, perhaps there is an indirect effect 
of p120-1 on Kaiso function mediated through p120-3. 
     In mammalian cancer models, Kaiso may actually increase the effect of Wnt 
signaling.  Kaiso knockout mice are viable and have no specific phenotype.  These mice 
also have no alteration in transcription of the Kaiso target genes Wnt11, S100A4, MTA2, 
or Rapsyn, suggesting a potential redundant function for Kaiso-like proteins in mammals 
(Prokhortchouk et al., 2006).  However, Kaiso knockout combined with Apcmin mice, a 
Wnt pathway-driven colorectal cancer mouse model, results in smaller intestinal tumors 
and longer survival than Apcmin mutation alone (Prokhortchouk et al., 2006).  In 
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colorectal cancer cell lines, Kaiso can bind to the methylated promoters of the tumor 
suppressors CDKN2A, HIC1, and MGMT in Colo320 and Hct116 cells.  When Kaiso is 
depleted, these genes are up-regulated and contribute to enhanced etoposide cytotoxicity 
(Lopes et al., 2008). 
     δ-catenin may also act similarly to p120 in that it can bind directly to Kaiso causing 
de-repression of MTA2, MMP7, and CCND1 transcription in A549 lung cancer cells (Dai 
et al., 2010).  However, no specific mention was made as to whether full-length δ-catenin 
(resembling p120-1) or an N-terminal truncation (resembling p120-3) interacts with 
Kaiso.  Both MMP7 and CCND1 are well-characterized targets of the canonical Wnt 
pathway  (Crawford et al., 1999; Polakis, 2012).  Another link to the role of p120 and δ-
catenin in Wnt signaling is that, like β-catenin, they have both been reported as targets of 
GSK3-beta phosphorylation (Hong et al., 2010; Oh et al., 2009).  Hong et al. show that 
p120-1 is serially phosphorylated by the β-catenin destruction complex and ubiquitylated 
by the βTrCP E3-ligase.  However, the GSK3β phosphorylation sites reported by Oh et al. 
are not analogus to those on p120-1.  The p120 interation with Kaiso is an important 
example of p120-mediated transcriptional control.  Regarding p120 isoforms, Kaiso 
specifically binds p120-3, Dyrk1A stabilizes p120-1, and Wnt mediates p120-1 
degradation.  These data imply that p120 isoforms are specifically involved in Wnt 
signaling through different but potentially related mechanisms. 
 
p120 and family in neural development 
     This dissertation characterizes the novel and specific interaction between p120-1 and 
Delta-Interacting Protein A (DIPA), encoded by the CCDC85B gene.  As described in 
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Chapter IV, DIPA also binds to ARVCF, p0071, and δ-catenin.  Because DIPA and 
p120-1 are highly expressed in brain tissue, I began searching for their physiologic 
function in the central nervous system.  This section is included to reveal relationships 
from the literature that have influenced my on-going efforts. 
     p120 isoform 1 and δ-catenin are abundantly expressed in the brain and play a role in 
normal cortical development.  The highest p120-1 expression is at the plasma membrane 
of choroid plexus and ependymal cells that lie within and surround the ventricles, which 
is consistent with its role in maintaining effective cellular adhesion (Chauvet et al., 2004).  
Neuroblasts that arise within the proliferative ventricular zone of the forebrain are also 
enriched with p120-1 (Chauvet et al., 2003).  These cells are highly motile and require 
rapid recycling of N-cadherin for both tangential and radial migration (Shikanai et al., 
2011).  Radial migration is a scaffold-cell dependent process that requires radial glial 
cells to form a track onto which migrating neurons adhere as they move distally 
(Kawauchi, 2012) (Fig. 3A).  Defects in radial migration result in ectopic accumulations 
of neurons in the deep layers of the neocortex, which are referred to as Periventricular 
Heterotopia (PVH) or Subcortical Band Heterotopia (SBH) depending on location.  
Respectively, these abnormalities reflect the failure of immature neurons either to initiate 
or continue migration outward from the proliferative ventricular zone to their position of 
function in the outer cortex.  Such malformations of cortical development can manifest as 
mental retardation, epilepsy, and microcephaly (Pang et al., 2008). 
     Genetic studies in humans and rodents have revealed surprisingly few genes that are 
mutated in abnormal neuronal migration syndromes.  The two most commonly mutated  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  p120 and abnormal cortical development.  A) Coronal sections of human 
brains: a) normal, b) lissencephaly, and c) SBH (arrow).  Schematics showing immature 
neurons (green) normally migrate from the ventricular zone along radial glial cells (blue) 
into the cortical plate, becoming mature neurons (orange).  Any defect in migration, glial 
formation, or ependymal cell (red) integrity will cause neurons to mature in the 
ventricular region or below the cortical plate, causing PVH or SBH respectively. B) 
Diagram of genes related to and mutated in PVH and SBH.
A 
B 
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genes in human PVH are FLNA, which encodes the actin-cytoskeletal protein Filamin-A  
(Sarkisian et al., 2008), and ARFGEF2, which regulates the molecular trafficking of 
Filamin-A (Kawauchi, 2012) (Fig. 3B).  Filamin-A was identified in a protein complex 
that was immunoprecipitated with anti-DIPA antibodies (see Chapter IV).  Factors other 
than neuronal migration are likely to contribute to PVH.  In the MEKK4-/- mouse model 
of PVH, ependymal cells along the ventricular surface have disrupted adherens junctions 
and basement membranes (Sarkisian et al., 2006).  Mechanistically, this defect is 
mediated in part by MEKK4 (a MAP3K) phosphorylation and activation of MKK4/SEK1 
(a MAP2K), which in-turn phosphorylates and stabilizes an excess of Filamin-A, but the 
physiologic consequence of ependymal dysfunction is a failure of radial glial cells to 
anchor properly.  Thus, the scaffold itself fails and neurons differentiate without leaving 
the ventricular zone (Sarkisian et al., 2008).  Clinical genetic data show that duplication 
and trisomy involving chromosome regions 5p15.1 – 5p15.33 are associated with PVH  
(Sheen et al., 2003).  Although there are multiple genes in this 20Mb region, it does 
contain the δ-catenin (CTNND2) locus at 5p15.2.  This connection to PVH is entirely 
speculative, and δ-catenin deletion alone does not cause heterotopia, but the association 
may be informative as more data are obtained.  The larger implication is that adherens 
junctional proteins may participate in cortical malformation pathogenesis through 
dysregulation of cell-cell contacts and/or Rho GTPases.   
     Genetic causes of the second malformation, SBH, have a more direct link to p120 and 
DIPA.  Human SBH is often associated with mutations in DCX, which encodes the 
microtubule-associated protein Doublecortin.  The c-Jun NH2-terminal Kinase (JNK, a 
MAPK) phosphorylates Doublecortin at neuron growth cones to stabilize microtubules 
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during migration (Gdalyahu et al., 2004).  JNK is activated by MKK4/SEK1, thus 
MEKK4 may be simultaneously affecting Filamin-A and DCX to regulate migration 
(Moriguchi et al., 1995) (Fig. 3B).  Another mutation, in the membrane fusion protein 
Soluble N-ethylmaleimide sensitive factor (NSF) attachment protein alpha (αSNAP), is 
the genetic error in the hydrocephalus with hop-gait (hyh) mouse, which also exhibits 
SBH (Chae et al., 2004).  αSNAP is a mediator of exocytosis and regulator of epithelial 
cell polarity that is required for p120 expression and adherens junction formation 
(Naydenov et al., 2012).  Another mutant mouse, hemorrhagic hydrocelphalus (hhy) 
exhibits SBH and is caused by a mutation in the CCDC85C gene, which encodes a poorly 
characterized protein containing two coiled-coil domains with 54% identity and 73% 
similarity to DIPA.  Because of p120-1 and δ-catenin function in cellular adhesion and 
migration during brain development, they are likely candidates as effectors in a 
neocortical patterning pathway, which may also involve DIPA and CCDC85C. 
     Studies examining the direct role of p120 in neural development do not show 
heterotopia or migratory failure, but p120 loss does result in synapse structure and 
function defects associated with mental retardation and neurodegeneration.  Floxed-p120 
gene deletion in mouse neuroepithelial precursors driven by an emx1-IRES-Cre 
recombinase results in normal cortical morphology (Elia et al., 2006). These data are 
surprising given the critical role of p120 in regulating cadherin function and cytoskeletal 
dynamics.  However, the high expression of δ-catenin in these neurons suggests that it 
can compensate for the p120 deficiency (Kawamura et al., 1999; Ho et al., 2000).  The 
selective deletion of p120 in neuroblasts does not test the requirement of radial glial cells 
to express and maintain N-cadherin.  Global knockout of p120 causes embryonic lethality 
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due to a failure of allantoic-chorionic membrane fusion, which precludes neural 
development studies (Birchmeier, 2012).   
     During neuronal migration, p120-1 is distributed in neural axons and growth cones but 
it is redistributed to dendrites and synapse-containing spines in mature neurons (Chauvet 
et al., 2003).  Although p120 knockout in neuroblasts does not disrupt gross brain 
architecture, individual pyramidal neurons in the hippocampus have reduced dentritic tree 
complexity, spine density, and synapse density.  Hippocampal extracts from p120 
knockout mice also have decreased Rac1 and increased RhoA activity (Elia et al., 2006).  
N-cadherin and p120-1 interaction in neurons is required for inhibiting RhoA, which 
allows for proper voltage-activated calcium channel function at synaptic junctions (Marrs 
et al., 2008).  
     Another neuronal function of p120 is to inhibit Amyloid β (Aβ) peptide formation by 
binding to Presenilin-1 (Kouchi et al., 2009).  Presenilin-1 is the catalytic component of 
the γ-secretase complex, which cleaves transmembrane proteins, including E-cadherin, 
N-cadherin, receptor tyrosine kinases, and Amyloid Precursor Protein (APP).  Presenilins 
are the most commonly mutated genes in familial Alzheimer’s Disease (De Strooper et 
al., 1998).  Alzheimer’s Disease and other neurodegenerative diseases have a 
characteristic accumulation of Aβ plaques, derived from APP cleavage (Cairns, 2009).  
In vitro p120 binding to E-cadherin decreases the Presenilin-1-mediated processing of 
APP and the amount of secreted Aβ (Kouchi et al., 2009).  p120-binding partner Dyrk1A 
(see above in p120, Kaiso, and Wnt signaling) is encoded by one of about 20 genes on 
chromosome 21 that are critical for Down’s Syndrome (trisomy 21) (Park et al., 2009).  
Dyrk1A phosphorylates Presenilin-1 causing increased γ-secretase activation, suggesting 
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a molecular pathway for the high incidence of early onset Alzheimer’s Disease in patients 
with Down’s Syndrome (Ryu et al., 2010).  p120 function in synapse maintenance and 
plaque formation is emerging as a potentially important factor in neurodegerative disease. 
     The p120 subfamily members are also implicated in neurodegeneration and other 
brain disorders. δ-catenin and p0071 directly interact with Presenilin-1 (Stahl et al., 1999; 
Zhou et al., 1997).  The interaction between δ-catenin and Presenilin-1 is essential for 
dendritic spine and synapse morphogenesis and function (Arikkath et al., 2009). δ-catenin 
deficient mice are viable and fertile but exhibit retracted dendrites, reduced spinal 
density, and decreased cortical responsiveness after 5 weeks of life (Matter et al., 2009).  
These morphologic and physiologic abnormalities contribute to cognitive and motor 
deficits, such as inability to navigate a water maze, impaired reaction to fearful stimuli, 
and decreased balance on a rotating rod (Israely et al., 2004). 
 
Summary and Significance 
     p120 mediates multiple cellular functions, such as cell adhesion, cytoskeletal 
arrangement, and transcriptional regulation.  Its specific relationships with cadherin 
stability and Rho inhibition suggest mechanisms in which p120 downregulation 
contributes to EMT and migration in development and disease.  p120 isoforms are largely 
under-studied and historically considered to have significantly overlapping functions.  
However, the data reviewed here suggest that different isoforms have specialized 
functions and p120-1 specifically is implicated in neuro-developmental and 
neurodegenerative diseases. 
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CHAPTER II 
 
MATERIALS AND METHODS 
 
Production of antigen 
     DIPA was cloned in to pBG100 (Center for Structural Biology, Vanderbilt 
University).  The sequence verified clone was transformed into Rosetta (DE3) E. coli 
cells.  Large-scale expression was carried out in 2 L of autoinduction media  (Studier, 
2005) at 37°C overnight.  Cell pellet was resuspended in 25 mM NaH2PO4, 500 mM 
NaCl, 10% Glycerol, (pH 8.0) with a total volume of 50 ml.  Resuspended cells were 
lysed during two passages under 15k to 20k psi using an Emulsiflex C3 (Avestin, Ottawa, 
ON).  Lysate was spun down at 130000 x g for two hours.  The clarified lysate was 
discarded and the pellet was resuspended in 25 mM NaH2PO4, 500 mM NaCl, 8 M Urea, 
(pH 8.0) and incubated at room temperature (RT) for one hour.  Cells were pelleted and 
the supernatant was added to Cobalt resin (Pierce, Rockford, IL) pre-equilibrated with 25 
mM NaH2PO4, 500 mM NaCl, 8 M Urea, (pH 8.0) and rotated overnight at RT.  The 
resin was separated with centrifugation, compacted in a disposable column, and washed 
with 10 column volumes of 25 mM NaH2PO4, 500 mM NaCl, 6 M Urea (pH 8.0).  The 
column was then washed with the same buffer with an additional imidazole gradient from 
0 mM to 250 mM.  Twenty-five 2 mL fractions were collected at a flow rate of 
approximately 1 mL/min.  Fractions were then analyzed by dot blot to ascertain the 
location of His-tagged protein using an Anti-6xHis antibody (Roche, Indianapolis, IN).  
Fractions containing 6xHis-tagged DIPA were subjected to SDS-PAGE and the cleanest 
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fractions were pooled for immunization, while fractions containing non-specific bands 
were pooled to screen immune sera. 
 
Immunization and hybridoma preparation 
     Four A/J mice (Stock #000646, Jackson Laboratory, Bar Harbor, ME) were injected 
both sub-dermally and intramuscularly in the thigh with a total of 50 µg of 6xHis-tagged 
full-length DIPA protein in Freud’s complete adjuvant.  At the same time, the mice were 
bled via the submandibular face vein to obtain a pre-bleed.  Sera were extracted by 
centrifugation using BD Microtainer tubes and evaluated for antigen-specific antibody 
titers using enzyme-linked immunosorbent assay (ELISA) as described below.  Four 
weeks after the initial immunization, the mice were boosted with the same dose of protein 
but utilizing incomplete adjuvant (also used in subsequent boosts).  After a two-week 
interval, the mice were again bled, and antibody titers were assessed by ELISA.  
Additional boosts were given at eight and 12 weeks after the initial immunization.  In 
each case, antibody sera titers were similarly evaluated two weeks after each 
immunization.   A single A/J mouse showing the most selective and concentrated anti-
DIPA titers was chosen for a final boost (50 µg) via an intraperitoneal injection without 
adjuvant.  Four days after this final boost, spleen cells were harvested and electro-fused  
(Yu et al., 2008) with Sp/20 (from Dr. William Sutherland, University of Virginia) or 
NS1 (from Dr. Robert Jeffery Hogan, University of Georgia) murine myeloma cells.  The 
products of the fusion were plated into methylcellulose-based semi-solid media 
(ClonaCell, Stemcell Technologies, Vancouver, BC) containing the selective reagents 
hypoxanthine, aminopterin, and thymidine (HAT). After approximately 10 days, colonies 
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of interest were picked and distributed individually into 96-well plates based on in situ 
interaction with fluorescently labeled mouse IgG-Fc 488 DyLight (Jackson Laboratory, 
catalog # 515-485-062) utilizing the ClonePix instrument (Genetix, Sunnyvale, CA).  
Individual clones were expanded in liquid media containing serum, hypoxanthine, and 
thymidine (Medium E, Stemcell Technologies, Vancouver) and maintained at a density 
of 5x105–1x106 cells/ml for generating antibody-rich supernatants.  Supernatants from 
hybridomas were assayed for antigen-specific antibodies by solid-phase ELISA, using 
full-length DIPA in sodium dodecyl sulfate (SDS) buffer as bait.  Positively scoring 
hybridomas were re-screened for performance by Western blotting, immunofluorescence, 
and immunoprecipitation.  The most promising anti-DIPA clones were selected, 
extensively subcloned to ensure monoclonality, and cryopreserved.  
 
ELISA procedure 
     The following solutions were prepared as follows from chemicals obtained from 
commercial sources; Carbonate-bicarbonate coating buffer (pH 9.6) was prepared from 
Na2CO3 (1.59 g/L), NaHCO3 (2.39 g/L), and thimerosal (0.10 g/L); PBS-Tween (pH 7.4) 
was prepared from NaCl (8.00 g/L), KH2PO4 (0.20 g/L), Na2HPO4 (1.15 g/L), KCl (0.20 
g/L), Tween 20 (1.00 mL/L), and thimerosal (0.10 g/L); BSA layered (5.0 g) on PBS-
Tween (500 mL); 1 nM ABTS solution in 70 mM citrate-phosphate buffer (pH 4.2) was 
prepared from citric acid (5.64 g/L), Na2HPO4 (5.84 g/L), and AzBTS-(NH4)2 (0.548 g).  
For ELISA experiments, ELISA quality plates (Immulon 2HB flat bottom microtiter 
plates 96 well or 4HB flat bottom 384 well plates) (Nunc, Rochester, NY) were coated 
with 10 mL per plate of a 5 µg/mL solution of DIPA antigen in carbonate bicarbonate 
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coating buffer and incubated at 4oC overnight.  Plates were washed three times with 100 
µL of PBS-Tween with a Bio-Tek ELx 405 automatic microplate washer (Winooski, VT) 
and incubated with 100 µL of PBS-Tween for 30 minutes at 37oC, after which the PBS 
contents were discarded.  Aliquots of murine sera dilutions or hybridoma supernatants 
(depending on the stage of the antibody development process) were incubated in the 
coated wells in a final volume of 100 µL in PBS for 60 minutes at 37oC.  The plates were 
then washed three times with PBS-Tween, followed by the addition of aliquots of diluted 
horse radish peroxidase (HRP)-conjugated affinipure goat anti-mouse IgG Fc region 
specific secondary antibody diluted in PBS-Tween/BSA at 1:5000 incubated at 37oC for 
60 minutes.  After washing the plates three times, ABTS solution was prepared (1.8 mL 
of H2O2 was added per 1 mL of ABTS) and immediately added to each well in 100 µL 
aliquots.  To determine peroxidase activity, absorbance at 414 nm was measured after 15 
and 30 minutes from each well using a Bio-Tek Powerwave HT 340 plate reader with 
Gen5 software (Winooski, VT).  Isotyping was done via ELISA per manufacturer’s 
protocol (mouse isotyping kit, catalog # 37503) (Pierce, Rockford, IL). 
 
Cells, tissue culture, and antibodies 
     All cell lines were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal calf serum (FCS), 2% L-glutamine, penicillin (100 U/mL), 
and streptomycin (100 mg/mL), (Gibco BRL, Gaithersburg, MD). The cell lines used to 
assess immunofluorescence, immunoblotting, and species cross-reactivity were A431 
epidermoid carcinoma cells (human), HCA7 colon carcinoma cells (human), HepG2 
hepatocarcinoma cells (human), HT29 colon carcinoma cells (human), IEC6 intestinal 
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epithelial cells (rat), MDCK kidney epithelial cells (canine), and NIH3T3 fibroblasts 
(mouse).  Anti-Flag MAb (M2 cat. #F1804) was purchased from Sigma-Aldrich (St. 
Louis, MO).  Anti-MBP (12B12), anti-Tubulin (DM1α), and KT3 MAbs 
(Tomonari1988) were obtained from the Vanderbilt Antibody and Protein Resource 
(Nashville, TN).  Anti-p120 monoclonal antibody pp120 was purchased from BD 
Transduction (San Jose, CA), and Anti-ZO-1 polyclonal antibody is from Santa Cruz 
Biotechnology (Santa Cruz, CA).   
 
Immunoblotting, immunoprecipitation, and immunofluorescence 
     Procedures for immunoblot analysis, immunoprecipitation, and immunofluorescence 
have been described previously in detail  (Daniel and Reynolds, 1999).  Briefly, cells 
were lysed in a buffer containing 0.5% Nonidet P-40, 10 mM Tris (pH 7.4), 150 mM 
NaCl, 1 mM phenylmethylsulfonyl fluoride, 1 mM ethylenediaminetetraacetic acid 
(EDTA), 1 mM sodium vanadate, 0.1 trypsin inhibitor units of aprotinin, and 5 mg of 
leupeptin per mL.  Whole cell lysates were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose 
membranes.  Blots were briefly blocked at 4°C with 5% non-fat dried milk in TBS pH 
7.4 and incubated overnight at 4°C with hybridoma supernatant or primary antibody 
(0.2–2.0 mg/mL) in 3% milk/TBS.  The membranes were then washed five times with 
TBS before incubation with the secondary anti-mouse 680 and/or anti-rabbit 800 
antibody (Licor, Lincoln, NE) in Odyssey blocking buffer/TBS for 30 min at RT.  Blots 
were finally washed three times with TBS plus 0.1% Tween-20 and three times with TBS 
and then processed with the Odyssey immunodetection system (Licor, Lincoln, NE) 
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according to the manufacturer’s protocols.  For immunoprecipitation, hybridoma 
supernatant or primary antibody was incubated with magnetic Dynabeads pre-conjugated 
to Protein G (Vanderbilt Antibody and Protein Resource, Nashville, TN) at 4°C for 2 
hours.  Dynabeads were then washed three times in NP-40 buffer and combined with 
whole cell lysates that were extracted as described above.  Dynabeads and lysate were 
incubated at 4°C for two hours before being washed three times with NP-40 buffer and 
solublizied in Laemlli Sample Buffer (LSB) (Daniel1999).  For immunofluorescent 
labeling, cells were plated and cultured for two days on glass coverslips before fixing 
with 3% paraformaldahyde (PFA) and permeabilization with 0.2% Triton X-100 in PBS 
(pH 7.4).  Primary antibody and hybridoma supernatant incubations were performed at 
RT for 30 min in 3% milk/PBS at 0.5–1.0 mg/mL. After washing three times with PBS, 
the coverslips were incubated with Alexa fluor donkey-anti-mouse 594 and/or Alexa 
fluor goat-anti-rabbit 488 (Life Technologies) secondary antibodies in 3% milk/PBS at 
1:800 dilution for 30 min at room temperature.  The coverslips were finally washed 3 
times with PBS, mounted on glass slides with Prolong Gold (Life Technologies), and 
visualized using a Zeiss Axioplan 2 microscope (Zeiss, Thornwood, NY). 
 
DIPA polyclonal antibody production and purification 
     The full-length 6xHis-tagged DIPA protein described above was used to immunize 
two New Zealand white rabbits by Covance (Princeton, NJ).  Sera was collected from 
both rabbits and tested by Western blot and immunofluorescence.  Polyclonal antibodies 
(PAbs) were subsequently purified from anti-sera by affinity chromatography on 
Protein-G sepharose (AKTA Xpress, GE Life Sciences, Piscataway, NJ). 
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DNA constructs and recombinant protein production 
     Full-length human DIPA (encoded by the CCDC85B gene) was purchased from the 
Dana Farber/Harvard Cancer Center DNA Resource Core (Cambridge, MA) in the form 
of pENTR223-CCDC85B-fusion (clone #HsCD00288507).  To create 3xFlag-DIPA, 
CCDC85B was recombined into the LZRS-GW-IRES-NeoR using LR recombinase from 
Life Technologies (Grand Island, NY).  Viral production and cell transduction protocols 
are described elsewhere (Ireton2002, Davis2003).  Maltose-binding protein (MBP)-
tagged DIPA protein and fragments were created by PCR cloning the CCDC85B gene 
into the pMal c2 vector (New England BioLabs, Ipswitch, MA).  To knockdown canine 
DIPA, shRNA constructs were ordered as oligomers, annealed, and cloned into 
pLentiLox3.7-Puro.  The specific targets are 1) 5’-GGGAGAACCTGGCGCTTAA-3’, 2) 
5’-GACTGAGGCTCATCTTCCT-3’, and 3) 5’-GCCTGGCTCTGGGTGAGGA-3’.  
The p120 knockdown and add-back constructs are described in  (Dohn and Reynolds, 
2009).  To create C-terminally tagged GFP-fusion proteins, p120-1A, p120-3, δ-catenin, 
and p0071 were PCR amplified, cloned pENTR2B, and recombined into pLentiLox3.7-
Gateway-GFP with LR recombinase from Life Technologies (Grand Island, NY). 
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CHAPTER III 
 
MONOCLONAL ANTIBODIES TO DIPA: A NOVEL BINDING PARTNER  
OF p120-CATENIN ISOFORM 1  
 
Introduction 
     p120 is a master regulator of classical cadherin stability and is important for epithelial 
homeostasis, development, tumorigenesis, and metastasis.  It is the prototypic member of 
a family that includes other Armadillo repeat-containing proteins ARVCF, γ-catenin, 
p0071, and plakophilins 1-3  (Reynolds, 2007).  In addition to, but not exclusive from, its 
regulation of cadherin turnover, p120 modulates activity of the Rho family small 
GTPases  (Anastasiadis et al., 2000; Dohn and Reynolds, 2009; Noren et al., 2000; 
Wildenberg et al., 2006).  The human p120 gene (CTNND1) encodes multiple spliced 
isoforms that range in size from about 75–120 kDa.  These isoforms comprise 
combinations of four different ATG start sites (1-4) and three alternatively spliced exons 
(A-C).  Although most cell types contain multiple isoforms, the long p120 isoform 1 and 
shorter isoform 3 are predominant in mesenchymal and epithelial cells, respectively  
(Keirsebilck et al., 1998).  Snail, Slug, and Twist transcription factors are embryonic 
Epithelial-Mesenchymal Transition (EMT) inducers that cause isoform switching from 
p120 isoform 3 to isoform 1 via the Epithelial Splicing Regulatory Proteins 1 and 2  
(Ohkubo and Ozawa, 2004; Sarrió et al., 2004; Warzecha et al., 2009) 
     During validation of a yeast two-hybrid screen using human p120 isoform 1AB as 
bait, I detected a p120 isoform 1-specific interaction with Delta-Interacting Protein A 
(DIPA).  DIPA was originally thought to bind the Hepatitis Delta Antigen  (Brazas and 
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Ganem, 1996) but has since been found to have no relationship to Hepatitis Delta  
(Taylor, 2009) .  DIPA is a 202-amino acid protein that contains two coiled-coil domains 
and no other identifiable domains.  At the protein level, it maintains a high degree of 
conservation with greater than 97% identity among mammals (Fig. 4).  Exogenous DIPA 
co-localizes with p78/MCRS1/MSP58 to centrosomes, and its over-expression can 
repress SRF and AP-1 signaling  (Du et al., 2006).  Endogenous DIPA can regulate 
adipocyte differentiation by inhibiting C/EBP-β and –γ  (Bezy et al., 2005).  When 
induced by p53 activation, DIPA can compete with β-catenin for binding to the TCF4 
transcription factor, which effectively down-regulates Wnt target gene expression  (Iwai 
et al., 2008).  Thus, DIPA is mostly found in the nucleus and appears to function 
primarily in transcriptional regulation.   
     The DIPA interaction with p120 is interesting in part because p120 is predominantly 
membrane-associated and functions in cadherin stability and cytoskeletal rearrangement.  
As an analogy, the well-known association of another cadherin binding partner β-catenin 
with TCF/LEF family members is critical for canonical Wnt signaling, which drives 
normal development and colorectal cancer.  TCF proteins can bind directly to β-catenin, 
DIPA, and the transcription factor Kaiso, a BTB/POZ zinc-finger protein first discovered 
as a p120 binding partner  (Daniel and Reynolds, 1999; Iwai et al., 2008; Ruzov et al., 
2009).  Notably, the β-catenin destruction complex, which is inhibited by Wnt 
stimulation and mutated in most colorectal cancer, appears to selectively ubiquitylate and 
degrade p120 isoform 1  (Hong et al., 2010).  Thus, several lines of evidence suggest that 
p120 isoform 1, and by association DIPA, is functionally distinct, perhaps analogous in 
some respects to the cytoplasmic pool of β-catenin involved in canonical Wnt signaling. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Alignment of human, canine, mouse, and rat DIPA proteins.  Reference 
sequences are from the NCBI Protein database, and ClustalW alignment was performed 
with MacVector software.  The non-identical amino acids are shaded, and the coiled-coil 
1 (42-90aa) and coiled-coil 2 (117-147aa) domains are boxed.
31 
32 
     To determine the function of DIPA and its relationship to p120, I have generated and 
characterized the first DIPA-specific monoclonal antibodies (MAbs). 
 
Results 
 
Initial characterization 
     Four mice were immunized with full-length 6xHis-tagged DIPA protein solubilized in 
6 M urea, and one mouse was picked based on anti-sera immunofluorescence and 
Western blotting.  Hybridoma generation yielded 423 ELISA-positive clones, but only 42 
clones were effective in Western blotting and immunofluorescence.  Further screening 
that included immunoprecipitation yielded five MAbs that were chosen for detailed 
characterization: 2G7, 3E3, 5E11, 8E11, and 15F11.  The results of these studies are 
presented in Figures 2 through 6, and their characteristics are summarized in Table 1. 
 
Immunoprecipitation and immunoblotting 
     To test the ability of these MAbs to detect denatured DIPA in an immunoblot assay, 
over-expressed 3xFlag-tagged DIPA was immunoprecipitated from transduced MDCK 
cells and subjected to Western blot analysis (Fig. 5A).  The membrane was cut into strips 
and probed by each of the MAbs.  The strip probed with an anti-Flag MAb was used as a 
positive control, and a DIPA rabbit polyclonal antibody (PAb) is shown for comparison.  
With the exception of MAb 2G7, all MAbs recognized two bands: a monomeric 3xFlag- 
  
 
 
 
 
 
 
 
 
 
Table 1.  Summary of anti-DIPA monclonal antibody characteristics 
IP, immunoprecipitation; WB, Western blotting; IF, immunofluorescence 
(-), no detection; (+), minimal detection; (++), good sensitivity or specificity;  (+++), 
good sensitivity and specificity 
Epitopes refer to recombinant DIPA fragments described in Fig. 6B.   
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Figure 5.  Reciprocal immunoprecipitations of exogenous DIPA.  (A) Anti-Flag MAb 
was used to immunoprecipitate 3xFlag-DIPA from NP-40-detergent cell lysates of 
transduced MDCK cells, and immunoprecipitates were separated by SDS-PAGE and 
transferred to nitrocellulose.  Dashed lines represent where individual strips of the 
nitrocellulose membrane were realigned after being probed separately.  Anti-Flag and 
DIPA PAb were used as controls.  The DIPA PAb was probed on the same strip as MAb 
15F11 but detected on a separate channel using the Odyssey imaging system.  (B) A 
portion of the same MDCK lysate from (A) was immunoprecipitated with each MAb, 
anti-Flag, or an irrelevant IgG control.  Precipitates were subjected to Western blotting as 
in (A) but probed with anti-Flag MAb.  MW, molecular weight marker.
A 
B 
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tagged DIPA of about 30 kDa and a higher molecular-weight species of about 75 kDa, 
which I believe may be a highly insoluble oligomer.   
     To identify the MAbs that recognize and immunoprecipitate 3xFlag-DIPA, I bound 
each MAb or an irrelevant mouse IgG MAb (KT3) to magnetic Dynabeads and 
subsequently incubated them with cleared lysate from MDCK cells expressing 3xFlag-
DIPA.  These lysates were then separated by SDS-PAGE, transferred to nitrocellulose, 
and probed by Western blotting with the anti-Flag MAb (Fig. 5B).  Again, MAb 3E3 
detected the DIPA oligomer, whereas the other MAbs could not.  2G7 was unable to 
immunoprecipitate 3xFlag-DIPA. 
     To determine the ability of these MAbs and the DIPA PAb to detect endogenous 
DIPA, I immunoblotted equal amounts of lysate from wild-type cell lines of rat, mouse, 
canine, or human origin (Fig. 6).  Cell lysate from MDCK cells over-expressing 3xFlag-
tagged DIPA was used as a positive control.  Lysate from MDCK cells with stably 
expressed shRNA against canine DIPA was used to test for specificity and to determine 
the migration of endogenous DIPA.  Endogenous monomeric DIPA (approximately 25 
kDa) migrates faster through the gel presumably because it lacks the 3xFlag epitope and 
amino acid linker in the exogenous DIPA.  MAb 3E3 does not react with a number of 
faint “background” bands recognized by the DIPA PAb (Fig. 6B and F).  MAb 3E3 was 
not able to detect DIPA from IEC6 or NIH3T3 cells, suggesting that either these cells 
express low levels of DIPA or MAb 3E3 may not cross-react with rodent DIPA.  MAb 
3E3 detected a faster migrating band that may represent a post-translationally modified 
DIPA, as previously reported  (Du et al., 2006).  Notably, the 75 kDa DIPA oligomer was  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Detection of endogenous DIPA by MAbs.  Cell lysates were isolated from 
IEC6 (rat), NIH3T3 (mouse), HCA7 (human), HT29 (human), A431 (human), HepG2 
(human), and three transduced MDCK (canine) cell lines with RIPA detergent.  Lysates 
were separated by SDS-PAGE (60 µg per lane) and transfered to nitrocellulose.  
Membranes in panels A-E were probed with MAbs 2G7, 3E3, 5G11, 8E11, and 15F11 
respectively.  Panel F represents the same membrane used in panel E that was probed 
with DIPA PAb and anti-Tubulin but detected on a separate channel using the Odyssey 
imaging system.   
MDCK Labels: 3x, lysate with over-expressing 3xFlag-DIPA; EV, lysate with empty 
vector; sh, lysate with stable expression of shRNA against canine DIPA. 
A 
B 
C 
D 
E 
F 
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not detectable in wild-type lysates.  It is apparent from panels B, E, and F that HCA7 
human colorectal cancer cells express a relatively large amount of DIPA.  
 
Immunofluorescence 
     To test the efficacy of the DIPA MAbs in immunofluorescence staining, I incubated 
fixed and permeabilized cells with the five different MAb hybridoma supernatants (Fig. 
7).  The MAbs showed predominantly nuclear and cytoplasmic staining in most cell lines, 
which is consistent with previous reports  (Bezy et al., 2005; Du et al., 2006; Iwai et al., 
2008).  Surprisingly, some antibodies recognized DIPA at cell-cell junctions, which is 
unreported in the literature.  MAbs 2G7 and 3E3 produced junctional staining patterns in 
MDCK cells.  MAbs 2G7 and 5G11 staining appeared at junctions in A431 cells, but 3E3 
did not.  Interestingly, 3E3 did not detect a robust nuclear pattern in NIH3T3 cells, but 
rather a low-intensity diffuse cytoplasmic staining with occasional nuclear 
accumulations.  15F11 produced low-intensity staining in all tested cell lines and had 
little nuclear staining. 
     I further characterized the MAb 3E3 by immunofluorescence because of its junctional 
staining pattern in MDCK cells, which is similar to that of p120  (Dohn and Reynolds, 
2009).  I co-stained control and DIPA-knockdown MDCK cells with MAb 3E3 and the 
DIPA PAb (Fig. 8).  As I expected, the polyclonal has high sensitivity but poor 
specificity evident by the persistent nuclear and Golgi-like staining in the DIPA-
knockdown cells.  However, the DIPA PAb junctional staining does not appear in the 
MDCK shDIPA cells.  The MAb 3E3 staining in all cell compartments almost completely  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.  Performance of anti-DIPA MAbs in immunofluorescence assays.  DIPA MAbs 
were incubated with PFA-fixed and TritonX-100-permeabilized cells as labeled.  Goat-
anti-mouse Alexa fluor 594 secondary antibodies were used to detect DIPA MAbs in all 
panels.  No primary antibodies were used in the bottom panels (2° only).  Insets show 
magnifications to better visualize DIPA junctional staining (arrows).  Bar = 50 µm
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Figure 8.  Comparison of MAb 3E3 and DIPA PAb by immunofluoresce.  MDCK cells 
stably expressing either non-silencing shRNA control (top) or canine DIPA-directed 
shRNA (bottom) were fixed, permeabilized, and probed with either DIPA PAb or the 3E3 
MAb.  Bar = 50 µm
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disappears in the DIPA-knockdown cells (Fig. 8).  Thus, I believe that both the nuclear 
and the cell-cell junctional staining represent endogenous DIPA. 
 
Epitope mapping 
     To determine the epitopes to which the DIPA MAbs bind, MBP-tagged full-length 
recombinant DIPA and five fragments (Fig. 9A) were produced using Rosetta E. coli.  
The tagged proteins were purified from bacterial lysates with maltose resin extraction, 
separated by SDS-PAGE, and detected by Western blotting using each of the five MAbs 
and an anti-MBP MAb (Fig. 9B).  Because the MBP tag is 42 kDa, all proteins migrated 
slower than endogenous DIPA.  All five MAb were able to detect the full-length DIPA.   
MAb 2G7 only detected the ΔC-term, CC2, and ΔCC1 fragments, and therefore its 
epitope lies between amino acids 118 and 149.  MAbs 3E3, 5G11, and 8E11 only 
detected ΔCC1 and C-term fragments, so they bind to DIPA between amino acids 142 
and 195.  MAb 15F11 detected the CC1 and ΔC-term fragments, therefore its epitope 
must be within the first 118 amino acids.  Some amount of protein degradation is evident 
in all lanes.  The higher molecular weight DIPA oligomer is appreciable in lanes 1, 4, and 
5 of the anti-MBP blot, which suggests that this species requires the CC2 domain for 
oligomerization.  Thus, these five DIPA MAbs recognize a diversity of epitopes that span 
the whole protein. 
 
Discussion 
     To better understand the physiologic function of DIPA and its relationship to p120 
isoform 1, I have generated a novel panel of MAbs against human full-length DIPA.  Of  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.  Epitope mapping of the DIPA MAbs.  (A) Schematic of full-length DIPA and 
five overlapping fragments.  The coiled-coil regions are labeled as “CC1” or “CC2,” and 
the terminal amino acid residues are indicated next to each fragment.  (B) Purified lysates 
from Rosetta BL-21 cells were separated by SDS-PAGE, transferred to nitrocellulose, 
and probed with each of the DIPA MAbs or anti-MBP as control.  Lanes 1-6 were loaded 
with lysates containing MBP-tagged full-length, CC1, ΔC-term, CC2, ΔCC2, and C-term 
DIPA respectively.
A 
B 
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the five MAbs characterized here, MAb 3E3 appears to be the most sensitive and specific 
by Western blotting and immunoprecipitation.  Although the data shown were generated 
with antibody supernatants, I have validated the results with purified MAb 3E3 and 
determined an optimal working concentration of 0.25 ug/mL for immunofluorescence 
and 1.0 ug/mL for Western blotting.  Interestingly, 3E3 was the only MAb that could 
immunoprecipitate the DIPA oligomer from MDCK cells over-expressing 3xFlag-DIPA 
(Fig. 5B).  Whether this higher molecular weight species exists endogenously is 
unknown, but it clearly forms when DIPA is over-expressed, because it is recognized by 
three distinct antibodies (i.e. anti-Flag, DIPA PAb, and anti-MBP) (Figs 5, 6F, and 9A).  
Once formed, the DIPA oligomer is highly insoluble, as it is unaffected by boiling in 
LSB containing β-mercaptoethanol and isolation by SDS-PAGE. 
     MAb 3E3 performed well in nearly all assays but does not appear to detect 
endogenous DIPA from the IEC6 (rat) or NIH3T3 (mouse) cell lines by Western blot.  
The MAb 3E3 epitope lies within the C-terminal region of DIPA (amino acids 142-195), 
and V158 is the only non-identical residue in rodent DIPA compared to human and 
canine.  It is possible that the 3E3 MAb requires a glycine at position 158 for binding.  
On the other hand, the abundance of DIPA in IEC6 and NIH3T3 cells may be below the 
threshold for immunoblot detection, because MAb 3E3 does detect an 
immunofluorescence signal in NIH3T3 cells (Fig. 7).  Further studies with shRNA and a 
DIPA point mutant will be required to answer this question.  Experimentally, it would be 
an advantage if MAb 3E3 recognizes only human and canine DIPA while the PAb detects 
all mammalian DIPA. 
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     The faster migrating band detected by MAb 3E3 (Fig. 6B) is likely to reflect 
phosphorylation of DIPA at T12.  Exogenous DIPA with a T12A point mutant has been 
detected as a single band by Western blot  (Du et al., 2006).  The T12 residue is predicted 
to be a casein kinase I and II substrate by NetPhos 2.0 (University of Denmark) and 
PhosphoMotif Finder (Human Protein Reference Database, Johns Hopkins University). 
     MAbs 2G7, 3E3, and 5G11 behaved similarly in immunofluorescence applications.  In 
addition to the more prominent nuclear staining, all three detected DIPA at cell-cell 
junctions. Although DIPA was not readily detected at junctions in all cell types, the result 
was clear in A431 and MDCK cells.  As noted, shRNA controls revealed MAb 3E3 to be 
highly specific when compared to the DIPA PAb (Fig. 8).  The differential junctional 
staining among MAbs 2G7, 3E3, and 15F11 in A431 and MDCK cells may reflect cell 
compartment-specific modifications or binding partners that differentially obscure 
epitopes. 
     In summary, I have generated five DIPA MAbs and characterized their performance in 
commonly used antibody-based assays.  They comprise diverse isotypes and interact with 
at least three distinct epitopes.  Of these, MAb 3E3 appears to be the best overall with 
respect to both specificity and performance in a variety of methods.   
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Chapter IV 
 
DIPA IS A NOVEL, ISOFORM-SPECIFIC BINDING PARTNER  
OF THE TUMORIGENESIS-ASSOCIATED p120 ISOFORM 1 
 
Introduction 
     Although p120 is well-known for its role in cadherin-mediated adherens junctions, it 
interacts with a number of novel binding partners in the cytoplasm and nucleus whose 
roles are, at best, indirectly related to adhesion.  Such recently discovered binding 
partners include Dyrk1A, RPTPµ tyrosine phosphatase, and CKIε  (Hong et al., 2012; 
Kim, 2011; Valle-Perez et al., 2011).  These findings have revealed new mechanisms for 
functions of p120 in development and cancer. 
     In addition, p120 is expressed as multiple isoforms, but the significance of this 
characteristic is not well understood.  p120-1 and p120-3 are the two major isoforms and 
their relative abundance is dependent on cell type and context.  p120-1 is particularly 
interesting because it is the only isoform that can rescue anchorage-independent growth 
in p120-knockdown MDCK cells transformed with dominant-active Rac1 (unpublished 
data; Dohn and Reynolds, 2009).  In lung cancer xengraphic mouse models, p120-1 over-
expression is permissive for tumorigenesis, but p120-3 is inhibitory (Liu et al., 2009).  
p120-1 is up-regulated at the expense of p120-3 during EMT (Ohkubo and Ozawa, 2004; 
Sarrió et al., 2004; Vandewalle et al., 2005).  Zeppo1, a novel metastasis-promoting 
transcriptional repressor, also induces p120 isoform switching from p120-3 to p120-1.  
Re-introducing p120-3 can repress the invasive phenotype bestowed on breast cancer 
cells by Zeppo1 (Slorach et al., 2011).  Up-regulation of p120-1 is closely correlated with 
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mesenchymal and metastatic behavior, suggesting an important, but so far unknown, 
function for the isoform-1 specific head domain.  As one approach to filling this gap, I 
conducted a yeast two-hybrid-based screening strategy to identify isoform-1 specific 
binding partners.  Of the potential candidates, DIPA was chosen for further 
characterization and functional analysis because of its relationship to other cancer-related 
proteins and pathways. 
     As described in chapter II, DIPA is a 202 amino acid protein with 2 internal coiled-
coil domains and no other conserved motifs.  It is predominantly a nuclear protein with 
transcription-repressing function through interactions with TCF4 and C/EBPβ (Iwai et 
al., 2008; Bezy et al., 2005).  DIPA itself is transcriptionally up-regulated by both 
Heregulin and Hepatocyte Growth Factor (HGF)  (Hellman et al., 2008; Saeki et al., 
2009).  Thus, DIPA is physically and functionally linked to a number of proteins with 
critical roles in cancer, but its function is not known. 
     Here, I show that DIPA and p120-1 interact specifically and that their functional 
disruption potentially underlies a genetic condition with abnormal brain development.  
First, the interaction is fine mapped in yeast two-hybrid assays.  Next, Madin-Darby 
Canine Kidney (MDCK) cells are used to show that endogenous DIPA is expressed at 
adherens junctions, which is dependent on p120.  Finally, δ-catenin and ARVCF are 
capable of rescuing junctional DIPA localization in the absence of p120. 
 
Results 
     In collaboration with Hybrigenics, I screened p120-1AB against a library comprised 
of cDNA from 4 breast cancer epithelial cell lines: T47D, MDA-MB468, MCF7, and 
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BT20.  To identify isoform-specific binding partners, I used direct yeast two-hybrid 
assays with readily available cDNAs to validate 23 of the 52 independent hits.  Candidate 
binding partners with a reproducible interaction to p120-1AB were then re-screened to 
test binding to p120-1A and 3A.  Secondary screening of isoform-specific binding 
partners by immunofluorescence and immunoprecipitation verified these interactions in 
mammalian cells.  Finally, to determine potential functional relevance, I tested whether 
the absence of p120 had an impact on the abundance or localization of a given hit. 
     The head domain of p120-1AB interacts with both DIPA coiled-coil domains.  To fine 
map their interaction, truncation mutants of p120 and DIPA were tested in direct yeast 
two-hybrid assays (Fig. 10).  Both DIPA coiled-coils are required for full-strength 
binding to p120-1AB, however, the N-terminal half of DIPA is sufficient for a weaker 
interaction.  Reciprocally, DIPA binds to p120-1AB and p120-1A, but not p120-3A.  The 
p120 N-terminal coiled-coil and regulatory domains together are sufficient for binding 
DIPA, but not the p120 coiled-coil by itself.  The p120 subfamily members ARVCF, 
p0071, and δ-catenin contain highly conserved N-terminal coiled-coil domains.  Both 
ARVCF and p0071 proteins interact with DIPA by direct yeast two-hybrid. δ-catenin was 
also tested but could not be interpreted because of high auto-activity in the GAL4-DNA-
binding domain fusion construct.  These direct yeast-two hybrid assays confirm that 
DIPA is a specific binding partner to the conserved head domain of p120-1 and p120 
subfamily members. 
     To validate the yeast two-hybrid data in mammalian cells, I conducted co-expression  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.  Schematic and yeast two-hybrid for p120-1 and DIPA interaction.  A) DIPA 
is shown at the top with coiled-coil domains 1 and 2 (CC1, CC2), and p120 is at the 
bottom with coiled-coil (CC), armadillo repeat (Arm), and alternatively spliced exons A 
and B.  Truncation fragments are represented by lines under each schematic.  B) Direct 
yeast two-hybrid assays were used with p120 genes fused to the GAL4-DNA binding 
domain and DIPA genes fused to the GAL4-activation domain.
A 
B 
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with knockdown and shRNA rescue experiments in a MDCK cell model.  MDCK cells 
exhibit classic epithelial morphology and form well defined cell-cell junctions that are 
ideal for high resolution co-localization studies.  Figure 11 shows that exogenous DIPA 
co-immunofluoresces (Fig. 11A) and co-immunoprecipitates (Fig. 11B) with p120-1A, 
but not p120-3A.  For Figure 11A, 3xFlag-tagged DIPA was introduced into MDCK cells 
by retroviral infection and then cells were stained with anti-Flag and anti-p120 
antibodies.  Note that 3xFlag-DIPA is expressed throughout wild type MDCK cells but 
predominantly in the cytoplasm and nucleus (Fig. 11A top row).  There is no dramatic 
change to the exogenous DIPA localization in p120 knockdown cells, but p120-1A 
rescue causes a striking recruitment of 3xFlag-DIPA to the cell membrane.  Rescue with 
p120-3A does not have this effect.  The same two cell lines from the bottom two rows of 
Figure 11A were used to co-immunoprecipitate 3xFlag-DIPA with the p120 monoclonal 
antibody pp120 (Fig. 11B).  Reciprocally, p120 was co-immunoprecipitated with DIPA 
using the anti-Flag monoclonal antibody.  Note that p120-3A does not immunoprecipitate 
with DIPA.  These data show that the isoform-specific interaction between DIPA and 
p120-1A can be recapitulated in mammalian cells. 
     To examine whether endogenous DIPA localizes to cell-cell junctions, a polyclonal 
antibody against full-length human DIPA was used to stain MDCK cells.  Figure 12A 
shows endogenous DIPA localization in wild type and control cells (top row), DIPA 
knockdown cells (middle row), and shRNA rescue cells (bottom row).  Note that the 
junctional, cytoplasmic, and nuclear staining patterns produced by this antibody are the 
same as observed with over-expressed 3xFlag-DIPA (compare Fig. 11 and Fig. 12).  
MDCK cell lines with stable DIPA knockdown and shRNA rescue show that the  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11.  Co-immunofluorescence and co-immunoprecipitation of p120-1 and DIPA.  
A) Immunofluorescence in MDCK cells with anti-Flag and F1aSH (anti-p120 polyclonal) 
antibodies. B) pp120 antibody immunoprecipitated exogenous p120-1, but not p120-3A, 
with 3xFlag-DIPA from MDCK lysates.  
A 
B 
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Figure 12.  Endogenous DIPA subcellular localization and co-immunoprecipitation with 
p120-1.  A) Specific DIPA junctional staining with the 337 polyclonal antibody in 
MDCK cells , which is absent in three different knockdown cell lines and rescued by 
human 3xFlag-DIPA expression.  B) Western blot of whole cell lysates from MDCK 
cells with shDIPA 1, 2, and 3.  (-) is a non-targeting shRNA control, and MW is the 
molecular weight marker.  C) Immunoprecipitation of p120-1 with DIPA 3E3 
monoclonal antibody.  The blot was probed with pp120 monoclonal antibody. 
A B 
C 
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junctional staining is specific with the known caveat that this antibody detects a non-
specific golgi-like antigen.  By immunoblotting, all three cell lines expressing DIPA 
knockdown constructs have reduced DIPA protein, but shDIPA1 and shDIPA3 are the 
most efficient (Fig. 12B).  To determine if endogenous DIPA and p120 interact, 3E3 
DIPA monoclonal antibody (described in Chapter III) was used to co-immunoprecipitate 
p120-1 in wild type MDCK cells (Fig. 12C).  Because DIPA co-migrates on SDS-PAGE 
with the 3E3 antibody light chain, I was unable to visualize endogenous DIPA in the 
p120 immunoprecipitate (data not shown).  These results show that endogenous DIPA 
localizes to the cell membrane and co-immunoprecipitates with p120-1. 
     The junctional localization of endogenous DIPA is dependent on p120-1 expression.  
MDCK cells expressing non-targeting control shRNA or p120 knockdown were stained 
with DIPA and either p120 polyclonal antibody or ZO-1 polyclonal antibody (Fig. 13).  
Control cells exhibit co-localization of endogenous DIPA and p120 (Fig. 13A, top row).  
But, cells with stable p120 knockdown fail to maintain adherens junctions and have 
reduced DIPA junctional staining (Fig. 13A, bottom row).  Tight junctions, however, are 
retained as represented by ZO-1 staining (Fig. 13B).  p120 and DIPA co-localize 
perfectly in adherens junctions, which is better visualized in the enlarged images in 
Figure 13C (top).  The tight junction marker ZO-1 does not co-localize with DIPA (Fig. 
13C, bottom).  These data provide further evidence for a model in which p120-1 is 
required to recruit DIPA to adherens junctions. 
     Yeast two-hybrid experiments showed that p120-1, ARVCF, and p0071 can all bind to 
DIPA.  These proteins, along with δ-catenin, all share a conserved head domain with a 
coiled-coil motif.  To identify p120 isoforms and/or family members capable of directly  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13A and B.  p120 is required for DIPA localization to adherens junctions.  Non-
targeting control shRNA or p120-knockdown shRNA were stably expressed in MDCK 
cells.  DIPA monoclonal antibody 3E3 was used to co-stain cells with either p120 
(F1aSH polyclonal antibody) or ZO-1 (polyclonal antibody). 
A 
B 
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Figure 13C.  DIPA co-localizes with p120 at adherens junctions and not tight junctions.  
C) Enlarged images of the merged panels from MDCK shRNA control cells, 13A (top) 
and 13B (bottom). 
C 
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recruiting DIPA to adherens junctions, MDCK cells with stable p120 knockdown were 
infected with retroviruses containing C-terminal GFP fusion proteins.  Figure 14 shows 
clearly that p120-1A-GFP, δ-catenin-GFP, and p0071-GFP can recruit endogenous DIPA 
to the cell membrane.  Neither p120-3A-GFP nor GFP alone can engage DIPA.  These 
results reveal that DIPA interacts with the p120 head domain and its subfamily members 
for junctional localization.  This finding potentially represents an evolutionarily 
conserved function for DIPA at adherens junctions. 
  
Discussion 
     The selective expression of p120-1 in mesenchymal cell types suggests a distinct role 
in mesenchymal functions, most likely mediated by its unique head domain.  One 
possibility is that the p120 head domain recruits to the adherens junction binding partners 
whose activities are essential for tumorigenesis, EMT, and/or metastasis.  Alternatively, 
the head domain itself has an unidentified activity though induction of structural, and thus 
functional, changes in adherens junctions. 
     DIPA is the first ever identified isoform-1 specific binding partner.  The yeast two-
hybrid data strongly suggest that the interaction is direct, although the unlikely possibility 
of an undetected bridge protein has yet to be ruled out.  Coiled-coil domains commonly 
participate in protein-protein interactions (Burkhard et al., 2001), and the p120 subfamily 
members have highly conserved N-terminal coiled-coils which interact with DIPA either 
by yeast two-hybrid or in MDCK cells.  These data suggest that the function of DIPA 
itself is highly conserved and might be effectively studied in the context of development.  
Indeed, DIPA proteins from all mammalian species share over 99% identity at the amino  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14.  p120-1A, Delta-catenin, and p0071 can rescue junctional DIPA expression in 
the absence of endogenous p120.  MDCK cells stably expressing p120-knockdown 
shRNA were infected with virus expressing GFP fusion proteins or GFP control.  DIPA 
was detected with the 337 polyclonal antibody. 
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acid level, and homologous DIPA proteins are found in reptiles and flies. 
     Our data show clearly that DIPA and p120-1 interact at adherens junctions.  
Moreover, membrane localization of DIPA is selectively dependent on p120-1 (Fig. 13 & 
14).  DIPA may influence cell-cell adhesion or cytoskeletal remodeling, however, 
experiments based on over-expression and/or knockdown of DIPA in MDCK cells reveal 
no changes in trans-epithelial resistance, adherens junction formation, or actin stress fiber 
formation (data not shown).  It is possible that DIPA does not have an active role at the 
membrane.  For example, p120-1 and its subfamily members may simply sequester DIPA 
from the nucleus where it presumably functions as a transcriptional repressor (Du et al., 
2006).  Though not well characterized, DIPA appears to function in a cascade of 
transcriptional events associated with adipogenesis.  Through its direct interaction with 
C/EBP-β and -γ, DIPA can repress differentiation of 3T3-L1 cells into adipocytes  (Bezy 
et al., 2005).  Interestingly, Kaiso was recently identified as an essential factor for the 
localization of SMRT, a transcriptional co-repressor, to the promotors of adipogenic 
genes (Raghav et al., 2012).  Exogenous expression of p120 itself in the cytoplasm of 
3T3-L1 can down-regulate adipogenesis (Kim, 2011).  The mechanisms of their 
interactions have not been elucidated, but p120 and its binding partners are emerging as 
important modulators of adipogenesis and, perhaps, mesenchymal fate determination. 
     In support of its role as a transcriptional regulator, p120 has previously been linked to 
TCF4, a Wnt pathway transcription factor inhibited by DIPA (Iwai et al., 2008).  In some 
model systems, Kaiso competes with TCF/LEF factors for access to target gene 
promoters, and p120-3 can promote Wnt signaling by sequestering Kaiso out of the 
nucleus  (Park et al., 2005; Hong et al., 2012).  It is possible by similarity that the p120-1 
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interaction with DIPA functions to relieve DIPA-mediated repression of TCF4 and 
promote Wnt pathway activity. 
     One potential role for DIPA is in regulation of adherens junctions during motility.  
HGF (also known as scatter factor) induces migration in epithelial cells through its 
receptor c-Met.  p120-1 promotes this motile phenotype and p120 mutants lacking the N-
terminal 78 amino acids prevent HGF-induced scattering (Cozzolino et al., 2003; 
Yanagisawa et al., 2008).  HGF also up-regulates DIPA transcription (Saeki et al., 2009).  
p120-1 or one of its subfamily members is clearly required for DIPA localization to cell 
junctions in MDCK cells (Fig. 12A, B).  One possibility is that DIPA is up-regulated by 
HGF to interact with p120-1 and regulate migration. 
     The identification of the DIPA and p120-1 interaction opens a window into 
mechanisms that regulate neuronal development and diseases of cortical malformation.  
Amino acids spanning the DIPA coiled-coil domains are 54% identical and 73% similar 
to a region within the CCDC85C protein.  The gene encoding CCDC85C has a 
pathogenic mutation in the recently described hemorrhagic hydrocephalus (hhy) mouse  
(Mori et al., 2011).  These mice develop Subcortical Band Heterotopia (SBH) stemming 
from a failure of neurons to migrate normally through the neocortex.  Consistent with 
SBH, the ependymal cells lining the lateral ventricals are dysmorphic, which contributes 
to the development of hydrocephalus.  Another p120-related protein, Soluble N-
ethylmaleimide sensitive factor (NSF) attachment protein alpha (αSNAP), is mutated in 
the hydrocephalus with hop-gait (hyh) mouse, which also has a SBH  (Chae et al., 2004).  
The αSNAP protein is a vesicle trafficking regulator that is required for p120-1 stability 
specifically and membrane localization of all p120 isoforms  (Naydenov et al., 2012).  
58 
Additionally, exogenous DIPA immunoprecipitates in a complex with the actin-
cytoskeletal protein Filamin-A, which is the most commonly dysregulated protein in 
human periventricular heterotopias (data not shown; Sarkisian et al., 2008).  It is 
unknown whether CCDC85C interacts directly with p120 or any of its subfamily 
members, or whether DIPA mutation causes developmental defects.  However, these 
results suggest a potential role for p120-1 and DIPA or CCDC85C in the molecular 
mechanisms of cortical development. 
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CHAPTER V 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Summary 
     This dissertation describes a project that began with an interest in understanding the 
role of specific p120 isoforms in cancer.  Through yeast two-hybrid screens and 
validation, DIPA was identified as the first ever p120-1 specific binding partner.  
Because of its relationships to cancer-related genes, I investigated DIPA as a likely key to 
unlocking the function of p120-1 in tumorigenesis. 
     The first half of this project comprised the building of novel reagents for studying 
DIPA and p120.  A panel of polyclonal and monoclonal antibodies were generated with 
specific affinity to DIPA, a series of DIPA knockdown and shRNA rescue cell lines were 
created, truncation mutants of DIPA and p120 were cloned, and fusion proteins of p120 
isoforms and family members were produced.  These tools continue to be critical to the 
project and have been helpful to other lab members. 
     The second half of the project focused on the characterization of the interaction 
between DIPA and p120.  First, DIPA was observed for the first time as a cell-cell 
junction-associated protein.  Secondly, precise co-localization and specific co-
immunoprecipitation was shown for DIPA and p120-1.  Finally, it was determined that 
p120-1 is required for DIPA junctional localization, and that p120 subfamily members 
can sufficiently rescue this phenotype in the absence of p120. 
     Behind the figures lie countless attempts to link the DIPA/p120 interaction to known 
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p120 functions, such as adherens junction formation and maintenance, RhoGTPase 
regulation, and Wnt signaling.  Other, more objective, assays were performed to 
determine the effect of DIPA over-expression or knockdown on cell proliferation, 
apoptosis, differentiation, EMT, and migration.  Not a single experiment showed that 
DIPA affected these processes. 
     Mere months before my scheduled defense date, a paper was published describing the 
pathogenic mutation in CCDC85C, which causes severe hemmorhagic hydrocephalus and 
subcortical band heterotopia (Mori et al., 2011).  Subsequent connections to DIPA and 
p120 biology were identified and the focus of my project shifted dramatically toward 
neural development. 
 
Future Directions 
     The significance of DIPA binding to p120 subfamily members is that the function of 
DIPA is likely conserved throughout evolution.  Also, the complexity of neural 
development may preclude tissue culture for phenotypic experiments.  Therefore, it is 
possible that a specific phenotype will be apparent if DIPA is manipulated in an 
experimentally favorable animal model.  To this end, I am currently collaborating with 
Caleb Doll and Josh Gamse, Ph.D. in the Vanderbilt Department of Biological Sciences 
to study the effects of DIPA over-expression and depletion in zebrafish neural 
development.  I have begun experiments with injection of DIPA mRNA or morpholinos 
into one-cell stage zebrafish embryos.  The aim of these studies is to determine if DIPA 
affects the migration and patterning of neurons in the cortex.  Initial results suggest a 
potential role for DIPA in neural tube development, but more studies are necessary for 
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validation. 
     DIPA and p120 may interact to affect specific cellular processes required for neuron 
migration and ependymal cell function that are perturbed in the hyh and hhy mutant mice.  
One such process is the regulation of cilia, which has not been tested with respect to 
DIPA function.  Primary cilia are essential for sonic hedgehog signaling, motility, and 
other aspects of brain development.  Motile cilia are closely related structures that line 
ependymal cells and function to maintain hydrostatic pressure within the ventricles.  
Failure of either primary cilia or motile cilia, as is seen in the hhy mouse, is causally 
associated with cortical malformation and/or hydrocephalus (Mori et al., 2011).  To 
determine the role of DIPA in primary cilia formation and maintanence, I have performed 
knockdown and shRNA rescue experiments in polarized MDCK cells.  The initial results 
suggest that DIPA is important for normal primary cilia formation, but further 
verification is required.    
     The data presented here also suggest that neural development may be regulated by 
DIPA and a p120 subfamily member, like δ-catenin.  Alternatively, the DIPA-like protein 
CCDC85C could bind to p120-1 or subfamily member and regulate a developmental 
function.  My future directions also include testing these interactions and investigating 
the possibility that the DIPA/p120 relationship is representative of a larger family of 
interacting proteins. 
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